πŸ‡ΊπŸ‡Έ FDA
Patent

US 6762020

Methods of diagnosing breast cancer

expired A61KA61K39/00

Quick answer

US patent 6762020 (Methods of diagnosing breast cancer) held by Protein Design Labs, Inc. expires Mon Jul 08 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Protein Design Labs, Inc.
Grant date
Tue Jul 13 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 08 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K39/00